Hints and tips:
...was not “knee-jerk” but had been under consideration for several years and accelerated following the integration and internal separation within the group of the two divisions following its acquisition of Solvay...
...of the US of Solvay Pharmaceuticals of Belgium....
...Abbott Laboratories on Friday announced the $3.7bn acquisition of the generic drugs unit of Indian conglomerate Piramal, in a move which significantly increases the US group’s emerging markets presence....
...Many companies have sealed deals to expand through acquisitions – such as Abbott’s purchase of Solvay, a European company with a strong presence in emerging markets....
...Pfizer last year paid $68bn to acquire its smaller US rival Wyeth, while Abbott Laboratories of the US bought Solvay of Belgium’s pharmaceuticals business for $6.5bn....
...Solvay Pharmaceuticals had sales of €2.7bn last year....
...Miles White, Abbott’s chairman and chief executive, said in a statement: “The acquisition of Solvay Pharmaceuticals further diversifies our pharmaceutical portfolio, expands our presence in key high-growth...
...Abbott Laboratories on Monday announced the €4.5bn ($6.6bn) acquisition of Solvay’s pharmaceutical company, bringing a five-month takeover battle to an end and highlighting continued consolidation in the...
...Abbott Laboratories agreed to pay $6.6bn in cash for the drugs unit of Belgian rival Solvay, bringing to an end a five-month takeover battle and highlighting continued consolidation in the industry....
...In the biggest pharma deal of the week, as the FT reports, Abbott Laboratories confirmed it will acquire a unit of Belgian conglomerate Solvay for €4.5bn, including its vaccine-making business....
...Solvay has whittled down the list of bidders for its pharmaceuticals business to Nycomed, the privately held Swiss company, and Abbott Laboratories of the US....
...Belgian pharmaceutical group Solvay gained 2.4 per cent to €75.90 following news reports that a potential bidding war was developing around the company’s drugs unit....
...Shares in Belgium’s Solvay hit a five-week high on Wednesday after it emerged that the pharmaceuticals and chemicals conglomerate had moved a step closer to offloading its drugs unit....
...In Belgium, shares in Solvay, the pharmaceutical company, dipped 0.1 per cent to €74.65 after US-based Abbott Laboratories agreed to pay $6.6bn in cash to buy out the Brussels-based company, bringing an...
International Edition